Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia | MicrobiomeTrials
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2014-10-14Est. Completion: 2027-08-11
Enrollment target: 37 participants
Locations
City of Hope Comprehensive Cancer Center, Duarte, California, United States